Hungary’s Richter expects Esmya drug ruling in first half: CEO

Print pagePDF pageEmail page

BUDAPEST (Reuters) – Hungarian drugmaker Richter expects European health inspectors to deliver a ruling on its Esmya medicine in the first half of 2018, its chief executive told Reuters, adding that uncertainty about the drug could delay earnings guidance.


Reuters: Health News … More ادامه مطلب

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.